Medicine to the test of crowds

Will the pill cure me or kill me? Should I medicate or change my lifestyle? No-one can tell. All in the name of patient confidentiality. 

Let’s tap wisdom of crowds to identify health dangers and benefits without risking personal information. Let’s guarantee ‘Live’ access to what works and what doesn’t. Open book policy. Anonymity guarantee.

Wisdom of crowds

We have a way to tap into the knowledge of crowds and share the work.

One. And a Billion

Health is both personal and universal. The solution for one may become the solution for a billion.

Privacy commons

We value our privacy, yet trust to share our information for the greater good. With Blockchain technology, we no longer need to make a trade-off.

Cure or profit

Corporate law requires companies to prioritize owners’ interest over those of society/customers. Medicine profits from treatment of sickness, not cures.

Secrecy fallacy

Medicine is secretive in the name of competition and patients’ interest. Is it time to democratize it and make people part of both the priorities, development, and cures?

Modern medicine power

Alternatives to monopolized patent Pharma treatments are wiped out by law or ridiculed by the best paid global lobby and media.

Doctor really?

58 of 64 oncologists don’t prescribe chemotherapy for themselves nor their families. Can we benefit from new collaboration between patients?

Same cure fits all?

Cure the masses is what pays? As people become connected, and individual data is shared and analyzed on a grand scale, new approaches to medicine can emerge.

Research is for Big Pharma?

Medical research. Health benefit claims. Expensive and reserved for Big Pharma? Could anyone do research and share the results?


Owned by its members (banks) ensures promotion, use and engagement.


Organized as a foundation to secure independence and avoid hostile takeovers. Runs profitable businesses that can be co-owned with others.


Crowdsource development. Democratize decisions. Keep it free (donations only).

Medicine to the test of crowds


Half of all medicated will experience that medicine do not work. Half will experience not reported side effects. Google is the primary medicine information source where users spend hundreds of hours.


J DOE empowers users to reliably and conveniently validate and search the real effects of medicine.


J DOE is crowd validated and guarantees user anonymity. J DOE presents real unedited user experience of medicine only. J DOE is organized to be independent  from the industry. J DOE revenue model is aligned with users.

Entry market

J DOE will secure top rank of users’ main search channel: Google. In one geography first: Norway. J DOE builds user engagement from free access for users.

Democratize Health:

Medicine to the test of crowds

Customer + Promise

Right customer: 25 interviews across 8 diagnosed and next-of-kins and 7 field experts concluded nutrition potential chronically ill people. With focus on recently diagnosed. 

Right promise: Uncertainty of effects of medication and sometimes severe side-effects preferred solved by insight into peer experience rather than packaging inserts and doctor experience.

Product + Delivery

Right product: 3 iterations of service with more validation clarity and opening to add-on services and secondary target groups of patient organizations and general practitioners (MDs).

Right delivery model: The one-stop-shop trusted anonymized validation platform perceived more convenient than Google search and peer hearsay. 

Revenue Model

Right revenue model: Patient organizations ready to pay per member to offer better information to their members and have stronger case arguments in lobbying. GPs ready to subscribe to J Doe as an independent source of real medicine use experience once we have more users. Endowments is an operations baseline option.

Is this your Moonwalk?

As a Moonwalk company, this startup is developed in 100 days stages from conception to growth. We are now approaching stage 3 of 4. Want to join us?

Apply now
100 Days Challenge & 100 Days Startup Project

Stage 1: Fall 2017

We now understand the Challenge – how to Democratize Medicine – better than anyone; we aligned our Approach; and framed our Constraints. 

Key Insights: We surfaced our Unfair Advantages, uncovered the Big Pains of our stakeholders; flipped the Domain Orthodoxies; and got inspired by Industry Disruptors.

Moonshots: We charted missions from our insights that can salvage pains of billions.

Startup Projects: We crafted and ranked a portfolio of startup projects that each solve parts of the challenge.

Stage 2: Spring 2018

Design & Prove Customer & Promise.
Design & Prove Product & Deliverability.
Design & Prove Revenue Model.

Join us for 7 weekends on-site in Oslo or online. Be a Customer Developer, Product Developer, or Revenue Model Developer.

100 Days Startup Pilot

Stage 3 of 4 starts September 2018. Apply now.

Minimum Viable Product: Prototype that works to unsupported showcase the customer experience.

Minimum Viable Market: Close to home first 10 customers (pre-sales).

Minimum Viable Team: Two to three people to cover Customer Promise/Sales and Product Development/Delivery and Revenue Model.

Minimum Viable Investment: Just Operating Expenses (time/prototype cost) of kr 600,000 ($75,000).

Are you a Customer Developer? A Product Developer? A Revenue Model Developer? Work for mix of shares and salary. 

Apply now
100 Days Startup Launch

Stage 4 of 4 starts February 2019. Apply now.

Launch version 1 of this startup.

Perfect Marketing & Sales: Find the keys to systematically attract and retain customers. 

Perfect Product & Delivery: Find the keys to systematically develop and deliver the product (service).

Perfect Revenue Model: Find the keys to systematically develop and operate the revenue model.

Minimum Viable Investment: Just Launch and Operating Expenses (time/product cost) of kr 1,000,000 ($125,000).

Are you a Customer Developer? A Product Developer? A Revenue Model Developer? Work for mix of shares and salary. 

Apply now